Den anden undersøgelse i Peru viste, at Dukorals beskyttende effektivitet efter en boosterdosis under det andet års opfølgning var 61%.
The other study in Peru showed that after a booster dose, the protective effectiveness of Dukoral during the second year of follow-up was 61%.